Jeffery J. Anderson
Keine laufenden Positionen mehr
Profil
Jeffery J.
Anderson worked as a Vice President-Clinical Sciences at Otonomy, Inc. He holds a doctorate degree from Indiana University and an undergraduate degree from the University of Dayton.
Ehemalige bekannte Positionen von Jeffery J. Anderson
| Unternehmen | Position | Ende |
|---|---|---|
| OTONOMY | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2022 |
Ausbildung von Jeffery J. Anderson
| Indiana University | Doctorate Degree |
| University of Dayton | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |